Increased expression of tyrosine phosphatase SHP-2 in Helicobacter pylori -infected gastric cancer

World Journal of Gastroenterology

Volumn 19, Issue 4, 2013, Pages 575-580

  Jiang, Jing ^a   Jin, Mei Shan ^a   Kong, Fei ^a   Wang, Yin Ping ^a   Jia, Zhi Fang ^a   Cao, Dong Hui ^a   Ma, Hong Xi ^a   Suo, Jian ^a   Cao, Xue Yuan ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

Expression; Gastric cancer; Helicobacter pylori; Sh2 containing protein tyrosine phosphatase 2

Indexed keywords

IMMUNOGLOBULIN G; PROTEIN TYROSINE PHOSPHATASE SHP 2;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE SPECIFIC SURVIVAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN EXPRESSION; STOMACH CANCER; STOMACH EPITHELIUM; TISSUE MICROARRAY;

EID: 84873682821     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i4.575     Document Type: Article

References (31)

1. Bray F, Jemal A, Grey N, Ferlay J, Forman D. Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol 2012; 13: 790-801 [PMID: 22658655 DOI: 10.1016/S1470-2045 (12)70211-5]
2. Kharitonenkov A, Chen Z, Sures I, Wang H, Schilling J, Ullrich A. A family of proteins that inhibit signalling through tyrosine kinase receptors. Nature 1997; 386: 181-186 [PMID: 9062191 DOI: 10.1038/386181a0]
3. Poole AW, Jones ML. A SHPing tale: perspectives on the regulation of SHP-1 and SHP-2 tyrosine phosphatases by the C-terminal tail. Cell Signal 2005; 17: 1323-1332 [PMID: 16084691 DOI: 10.1016/j.cellsig.2005.05.016]
4. Qu CK. Role of the SHP-2 tyrosine phosphatase in cytokineinduced signaling and cellular response. Biochim Biophys Acta 2002; 1592: 297-301 [PMID: 12421673 DOI: 10.1016/ S0167-4889(02)00322-1]
5. You M, Flick LM, Yu D, Feng GS. Modulation of the nuclear factor kappa B pathway by Shp-2 tyrosine phosphatase in mediating the induction of interleukin (IL)-6 by IL-1 or tumor necrosis factor. J Exp Med 2001; 193: 101-110 [PMID: 11136824 DOI: 10.1084/jem.193.1.101]
6. Tseng PC, Huang WC, Chen CL, Sheu BS, Shan YS, Tsai CC, Wang CY, Chen SO, Hsieh CY, Lin CF. Regulation of SHP2 by PTEN/AKT/GSK-3β signaling facilitates IFN-γ resistance in hyperproliferating gastric cancer. Immunobiology 2012; 217: 926-934 [PMID: 22325465 DOI: 10.1016/ j.imbio.2012.01.001]
7. Chan RJ, Feng GS. PTPN11 is the first identified protooncogene that encodes a tyrosine phosphatase. Blood 2007; 109: 862-867 [PMID: 17053061 DOI: 10.1182/blood-2006 -07-028829]
8. Chan G, Kalaitzidis D, Neel BG. The tyrosine phosphatase Shp2 (PTPN11) in cancer. Cancer Metastasis Rev 2008; 27: 179-192 [PMID: 18286234 DOI: 10.1007/s10555-008-9126-y]
9. Meng F, Zhao X, Zhang S. Expression and significance of SHP-2 in human papillomavirus infected cervical cancer. J Huazhong Univ Sci Technolog Med Sci 2012; 32: 247-251 [PMID: 22528229 DOI: 10.1007/s11596-012-0044-4]
10. Jiang C, Hu F, Tai Y, Du J, Mao B, Yuan Z, Wang Y, Wei L. The tumor suppressor role of Src homology phosphotyrosine phosphatase 2 in hepatocellular carcinoma. J Cancer Res Clin Oncol 2012; 138: 637-646 [PMID: 22228034 DOI: 10.1007/s00432-011-1143-5]
11. Bard-Chapeau EA, Li S, Ding J, Zhang SS, Zhu HH, Princen F, Fang DD, Han T, Bailly-Maitre B, Poli V, Varki NM, Wang H, Feng GS. Ptpn11/Shp2 acts as a tumor suppressor in hepatocellular carcinogenesis. Cancer Cell 2011; 19: 629-639 [PMID: 21575863 DOI: 10.1016/j.ccr.2011.03.023]
12. Hatakeyama M. Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat Rev Cancer 2004; 4: 688-694 [PMID: 15343275 DOI: 10.1038/nrc1433]
13. Kim JS, Shin OR, Kim HK, Cho YS, An CH, Lim KW, Kim SS. Overexpression of protein phosphatase non-receptor type 11 (PTPN11) in gastric carcinomas. Dig Dis Sci 2010; 55: 1565-1569 [PMID: 19690960 DOI: 10.1007/s10620-009- 0924-z]
14. Higashi H, Tsutsumi R, Muto S, Sugiyama T, Azuma T, Asaka M, Hatakeyama M. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 2002; 295: 683-686 [PMID: 11743164]
15. Higashi H, Nakaya A, Tsutsumi R, Yokoyama K, Fujii Y, Ishikawa S, Higuchi M, Takahashi A, Kurashima Y, Teishikata Y, Tanaka S, Azuma T, Hatakeyama M. Helicobacter pylori CagA induces Ras-independent morphogenetic response through SHP-2 recruitment and activation. J Biol Chem 2004; 279: 17205-17216 [PMID: 14963045 DOI: 10.1074/ jbc.M309964200]
16. Zhou X, Coad J, Ducatman B, Agazie YM. SHP2 is upregulated in breast cancer cells and in infiltrating ductal carcinoma of the breast, implying its involvement in breast oncogenesis. Histopathology 2008; 53: 389-402 [PMID: 18643929 DOI: 10.1111/j.1365-2559.2008.03103.x]
17. Yu SJ, Yu JK, Ge WT, Hu HG, Yuan Y, Zheng S. SPARCL1, Shp2, MSH2, E-cadherin, p53, ADCY-2 and MAPK are prognosis-related in colorectal cancer. World J Gastroenterol 2011; 17: 2028-2036 [PMID: 21528083 DOI: 10.3748/wjg.v17. i15.2028]
18. Zhou X, Agazie YM. Molecular mechanism for SHP2 in promoting HER2-induced signaling and transformation. J Biol Chem 2009; 284: 12226-12234 [PMID: 19261604 DOI: 10.1074/ jbc.M900020200]
19. Tsai CC, Kai JI, Huang WC, Wang CY, Wang Y, Chen CL, Fang YT, Lin YS, Anderson R, Chen SH, Tsao CW, Lin CF. Glycogen synthase kinase-3beta facilitates IFN-gammainduced STAT1 activation by regulating Src homology-2 domain-containing phosphatase 2. J Immunol 2009; 183: 856-864 [PMID: 19542364 DOI: 10.4049/jimmunol.0804033]
20. Du Z, Shen Y, Yang W, Mecklenbrauker I, Neel BG, Ivashkiv LB. Inhibition of IFN-alpha signaling by a PKC- and protein tyrosine phosphatase SHP-2-dependent pathway. Proc Natl Acad Sci USA 2005; 102: 10267-10272 [PMID: 16000408 DOI: 10.1073/pnas.0408854102]
21. Kim HY, Park EJ, Joe EH, Jou I. Curcumin suppresses Janus kinase-STAT inflammatory signaling through activation of Src homology 2 domain-containing tyrosine phosphatase 2 in brain microglia. J Immunol 2003; 171: 6072-6079 [PMID: 14634121]
22. Hong F, Nguyen VA, Gao B. Tumor necrosis factor alpha attenuates interferon alpha signaling in the liver: involvement of SOCS3 and SHP2 and implication in resistance to interferon therapy. FASEB J 2001; 15: 1595-1597 [PMID: 11427497]
23. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum 1994; 61: 1-241 [PMID: 7715068]
24. Tsutsumi R, Higashi H, Higuchi M, Okada M, Hatakeyama M. Attenuation of Helicobacter pylori CagA x SHP-2 signaling by interaction between CagA and C-terminal Src kinase. J Biol Chem 2003; 278: 3664-3670 [PMID: 12446738 DOI: 10.1074/jbc.M208155200]
25. Truong BX, Mai VT, Tanaka H, Ly le T, Thong TM, Hai HH, Van Long D, Furumatsu K, Yoshida M, Kutsumi H, Azuma T. Diverse characteristics of the CagA gene of Helicobacter pylori strains collected from patients from southern vietnam with gastric cancer and peptic ulcer. J Clin Microbiol 2009; 47: 4021-4028 [PMID: 19846630 DOI: 10.1128/JCM.00504-09]
26. Higuchi M, Tsutsumi R, Higashi H, Hatakeyama M. Conditional gene silencing utilizing the lac repressor reveals a role of SHP-2 in cagA-positive Helicobacter pylori pathogenicity. Cancer Sci 2004; 95: 442-447 [PMID: 15132773 DOI: 10.1111/j.1349-7006.2004.tb03229.x]
27. Jiang J, Jia ZF, Kong F, Jin MS, Wang YP, Tian S, Suo J, Cao X. Association of polymorphism of PTPN 11 encoding SHP-2 with gastric atrophy but not gastric cancer in Helicobacter pylori seropositive Chinese population. BMC Gastroenterol 2012; 12: 89 [PMID: 22788847 DOI: 10.1186/1471-230X-12-89]
28. Feng H, Liu KW, Guo P, Zhang P, Cheng T, McNiven MA, Johnson GR, Hu B, Cheng SY. Dynamin 2 mediates PDGFRα- SHP-2-promoted glioblastoma growth and invasion. Oncogene 2012; 31: 2691-2702 [PMID: 21996738 DOI: 10.1038/ onc.2011.436]
29. Aceto N, Sausgruber N, Brinkhaus H, Gaidatzis D, Martiny- Baron G, Mazzarol G, Confalonieri S, Quarto M, Hu G, Balwierz PJ, Pachkov M, Elledge SJ, van Nimwegen E, Stadler MB, Bentires-Alj M. Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loop. Nat Med 2012; 18: 529-537 [PMID: 22388088 DOI: 10.1038/nm.2645]
30. Lee KS, Kalantzis A, Jackson CB, O'Connor L, Murata-Kamiya N, Hatakeyama M, Judd LM, Giraud AS, Menheniott TR. Helicobacter pylori CagA triggers expression of the bactericidal lectin REG3γ via gastric STAT3 activation. PLoS One 2012; 7: e30786 [PMID: 22312430 DOI: 10.1371/journal. pone.0030786]
31. Miyamoto D, Miyamoto M, Takahashi A, Yomogita Y, Higashi H, Kondo S, Hatakeyama M. Isolation of a distinct class of gain-of-function SHP-2 mutants with oncogenic RAS-like transforming activity from solid tumors. Oncogene 2008; 27: 3508-3515 [PMID: 18223690 DOI: 10.1038/ sj.onc.1211019]